Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis

BACKGROUND: The first cases of the coronavirus disease 2019 (COVID-19) were reported in Wuhan, China. No antiviral treatment options are currently available with proven clinical efficacy. However, preliminary findings from phase III trials suggest that remdesivir is an effective and safe treatment o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Emerg Med
Autors principals: Sarfraz, Azza, Sarfraz, Zouina, Sanchez-Gonzalez, Marcos, Michel, Jack, Michel, George, Frontela, Odalys, Posada, Jorge, Cardona, Jose, Angueira, Eugenio
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer - Medknow 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091999/
https://ncbi.nlm.nih.gov/pubmed/33969238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2452-2473.309139
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars